Sector Gamma As Vertex Pharmaceuticals Inc Transaction History

Sector Gamma As

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$234.96 - $292.55 $2.05 Million - $2.55 Million	8,716 Added 35.2%	33,474 $9.43 Million
Q1 2022 May 06, 2022	SELL	$221.42 - $260.97 $3.17 Million - $3.73 Million	-14,311 Reduced 36.63%	24,758 $6.46 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $6.92 Million - $8.73 Million	39,069 New	39,069 $8.58 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.